Reports from Norway about deaths in very frail, elderly patients soon after receiving Pfizer/BioNTech’s COVID-19 jab have drawn regulatory scrutiny. While the European Medicines Agency has launched an investigation, Australia is examining the need for specific warnings about risks of vaccination in the very frail elderly or terminally ill patients.
Regulators worldwide are paying close attention to recent reports of death in Norway in very frail, elderly people soon after receiving the Pfizer/BioNTech COVID-19 vaccine Comirnaty.
Following reports of around 30 deaths in this subgroup, Pfizer initially stated that Norway had changed its recommendations in...